Medicinova (MNOV) Other Working Capital Changes (2020 - 2025)
Medicinova (MNOV) posted quarterly Other Working Capital Changes of -$43418.0 for Q4 2025, up 10.76% year-over-year from -$39199.5 in Q4 2024, and up 6.98% quarter-over-quarter from -$46674.0 in Q3 2025.
Medicinova (MNOV) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Medicinova (MNOV) has reported Other Working Capital Changes for 6 consecutive years, with -$43418.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 10.76% year-over-year to -$43418.0; the TTM figure through Dec 2025 stood at -$195010.0 (down 10.67% YoY), while the FY2025 annual figure was -$195010.0, down 10.67% from the prior year.
- Other Working Capital Changes climbed to -$43418.0 in Q4 2025 per MNOV's latest filing, from -$46674.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $554172.0 in Q1 2022 and bottomed at -$755820.0 in Q4 2024.
- Historically, Other Working Capital Changes has averaged -$5919.6 across 5 years, with a median of -$106688.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes soared 55.81% — and 2023, when it slumped 91.54%.
- Medicinova's Other Working Capital Changes stood at -$62655.0 in 2021, then jumped by 33.3% to -$41789.0 in 2022, then decreased by 16.01% to -$48479.0 in 2023, then retreated by 0.36% to -$48654.0 in 2024, then increased by 10.76% to -$43418.0 in 2025.
- Business Quant data shows MNOV's Other Working Capital Changes at -$43418.0 in Q4 2025, -$46674.0 in Q3 2025, and -$53708.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -43,418.00 |
| Dec 31, 2025 | -43,418.00 |
| Dec 31, 2025 | -43,418.00 |
| Sep 30, 2025 | -46,674.00 |
| Sep 30, 2025 | -46,674.00 |
| Sep 30, 2025 | -46,674.00 |
| Jun 30, 2025 | -53,708.00 |
| Jun 30, 2025 | -53,708.00 |
| Jun 30, 2025 | -53,708.00 |
| Mar 31, 2025 | -51,210.00 |
| Mar 31, 2025 | -51,210.00 |
| Mar 31, 2025 | -51,210.00 |
| Dec 31, 2024 | -48,654.00 |
| Dec 31, 2024 | -48,654.00 |
| Dec 31, 2024 | -48,654.00 |
| Sep 30, 2024 | -40,230.00 |
| Sep 30, 2024 | -40,230.00 |
| Sep 30, 2024 | -40,230.00 |
| Jun 30, 2024 | -36,513.00 |
| Jun 30, 2024 | -36,513.00 |